VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $19,835,000 | -24.0% | 1,245,919 | -0.8% | 1.06% | -21.1% |
| Q4 2017 | $26,094,000 | +76.4% | 1,255,723 | +21.6% | 1.34% | +72.0% |
| Q3 2017 | $14,796,000 | -17.0% | 1,032,553 | +0.3% | 0.78% | -20.0% |
| Q2 2017 | $17,817,000 | +84.9% | 1,029,857 | +17.9% | 0.98% | +79.1% |
| Q1 2017 | $9,634,000 | -51.2% | 873,445 | -35.8% | 0.54% | -2.3% |
| Q4 2016 | $19,758,000 | +13.0% | 1,360,702 | +91.0% | 0.56% | +3.0% |
| Q3 2016 | $17,488,000 | +24.7% | 712,336 | +2.3% | 0.54% | +17.8% |
| Q2 2016 | $14,020,000 | -4.0% | 696,104 | +25.3% | 0.46% | -1.9% |
| Q1 2016 | $14,606,000 | -70.8% | 555,338 | +12.8% | 0.47% | -69.8% |
| Q4 2015 | $50,058,000 | – | 492,456 | – | 1.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |